Clostridium Butyricum CBM588® vs. Rifaximin for Symptomatic Uncomplicated Diverticular Disease (SUDD): A Real-World Retrospective Study
Clinical trial NCT06852274 · COMPLETED
Trial details
- NCT number
- NCT06852274
- Sponsor
- Dr. Amjad Khan
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-04-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.